|Traded as||NASDAQ: NH|
Russell 2000 Index component
|Founded||Culver City, California (2007 )|
|Patrick Soon-Shiong (CEO)|
Paul Holt (CFO)
|Footnotes / references|
NantHealth is one of the constituent companies of NantWorks, which is controlled by Patrick Soon-Shiong. With headquarters in Culver City, California, the firm is focused on developing and marketing a range of healthcare solutions.[clarification needed]
In September 2014, NantHealth was featured as the cover story on Forbes Magazine, where it was estimated that NantHealth has a market value of $1.6 billion. In December 2014, NantHealth was featured on 60 Minutes by Sanjay Gupta. In August 2017, NantHealth signed a distribution agreement for GPS Cancer with Asia Genomics.
In January 2019, NantHealth received a delisting warning from Nasdaq "because the Company’s common stock failed to maintain a minimum closing bid price of $1.00 for 30 consecutive business days." At the time, the market value of the company was approximately $57m.
- "About: Company". NantHealth. Retrieved 2018-04-10.
- "NantHealth Investment deal paves way for IPO". Retrieved 1 July 2015.
- "BlackBerry Invests in NantHealth for Integrated End-To-End Healthcare Solutions". Retrieved 5 February 2015.
- "Soon-Shiong's NantHealth Raises $250 Million From Kuwait Fund". Retrieved 5 February 2015.
- "Celgene Makes Landmark Investment in NantHealth to Advance Groudbreaking Cancer Research for Patients". Retrieved 5 February 2015.
- "Verizon invests in NantHealth to deliver mobile clinical data". Retrieved 5 February 2015.
- "Can Patrick Soon-Shiong, The World's Richest Doctor, Fix Health Care?". Retrieved 5 February 2015.
- "Disrupting Cancer". Retrieved 5 February 2015.
- "NantHealth Signs Distribution Deal for GPS Cancer in Southeast Asia". GenomeWeb. Retrieved 2018-10-23.
- "Document". www.sec.gov. Retrieved 2019-02-09.
- "NH : Summary for NantHealth, Inc. - Yahoo Finance". finance.yahoo.com. Retrieved 2019-02-09.
|This article about a medical, pharmaceutical or biotechnological corporation or company is a stub. You can help Wikipedia by expanding it.|